Cited by 874Cancer, Stress, Anesthesia, and Immune ResponseCancer survivorship and careTryptophan and brain disorders

The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.

Depression and cancer: mechanisms and disease progression

Spiegel, David, Giese-Davis, Janine·2003·Biological Psychiatry

Abstract

Depression and cancer commonly co-occur. The prevalence of depression among cancer patients increases with disease severity and symptoms such as pain and fatigue. The literature on depression as a predictor of cancer incidence is mixed, although chronic and severe depression may be associated with elevated cancer risk. There is divided but stronger evidence that depression predicts cancer progression and mortality, although disentangling the deleterious effects of disease progression on mood complicates this research, as does the fact that some symptoms of cancer and its treatment mimic depression. There is evidence that providing psychosocial support reduces depression, anxiety, and pain, and may increase survival time with cancer, although studies in this latter area are also divided. Psychophysiological mechanisms linking depression and cancer progression include dysregulation of the hypothalamic-pituitary-adrenal axis, especially diurnal variation in cortisol and melatonin. Depression also affects components of immune function that may affect cancer surveillance. Thus, there is evidence of a bidirectional relationship between cancer and depression, offering new opportunities for therapeutic intervention.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0006-3223(03)00566-3

Cites

149 of 149 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 147 references

Research works printed but not linked: 6

  1. Ilnyckyj, 1994, A randomized controlled trial of psychotherapeutic intervention in cancer patients, Ann R Coll Physicians Surg Can, 27, 93
  2. Kuchler, 1999, Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery, Hepatogastroenterology, 46, 322
  3. Landmann, 1984, Changes of immunoregulatory cells induced by psychological and physical stress, Clin Exp Immunol, 58, 127
  4. Lerman, 1994, Younger women at increased risk for breast cancer, J Natl Cancer Inst Monogr, 16, 171
  5. Mormont, 2002, Cortisol diurnal variation in blood and saliva of patients with metastatic colorectal cancer, Anticancer Res, 22, 1243
  6. Wellisch, 1991, Psychosocial outcomes of breast cancer therapies, Psychosomatics, 32, 177

Cited by

Sorted by citations

Items 101–200 of 874

Metadata

Authors
Spiegel, D., & Giese-Davis, J.
Affiliations
Stanford Medicine (US)
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2003-08
Volume
54
Issue
3
Pages
269-282
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2032018235
Cited by
874
References
147
Citations by year
2026: 27 · 2025: 36 · 2024: 36 · 2023: 35 · 2022: 42 · 2021: 42 · 2020: 55 · 2019: 43 · 2018: 44 · 2017: 28 · 2016: 37 · 2015: 42 · 2014: 36 · 2013: 40 · 2012: 58
FWCI
3.61
Type
journal article
Language
en
Open access
closed
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Cancer Institute
  • National Institutes of Health (5R01 MH047226)
  • National Institute of Mental Health (5P01AG018784)
  • National Institute on Aging
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
depression, cancer, tumor progression, cancer mortality, cancer incidence, psychosocial support, hypothalamic-pituitary-adrenal axis, cortisol, melatonin, immune function, cancer surveillance, pain, fatigue, bidirectional relationship
MeSH terms
Adrenal Glands, Depressive Disorder, Humans, Hypothalamo-Hypophyseal System, Neoplasms, Risk Factors, Treatment Refusal, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review